Sporos Launches with $38.1 Million Series A Financing

NEXT STORY
Predictmedix announces technology deployment at Long Term Care residence in Edmonton, in partnership with Optima Living
PREV STORY
Agenus Corporate Update and First Quarter 2021 Financial Report
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Apellis and Sobi: The New England Journal of Medicine Publishes Phase 3 PEGASUS Study Results Comparing Pegcetacoplan to Eculizumab for PNH

author_avatar
NASDAQ Market News

Shire plc : FDA APPROVES VONVENDI® FOR PERIOPERATIVE MANAGEMENT OF BLEEDING IN ADULT PATIENTS WITH VON WILLEBRAND DISEASE

author_avatar
NASDAQ Market News

TRACON Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Corporate Update

author_avatar
NASDAQ Market News